Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AC Immune (ACIU) Accumulated Expenses: 2014-2025

Historic Accumulated Expenses for AC Immune (ACIU) over the last 9 years, with Sep 2025 value amounting to $15.0 million.

  • AC Immune's Accumulated Expenses rose 0.70% to $15.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $15.0 million, marking a year-over-year increase of 0.70%. This contributed to the annual value of $15.0 million for FY2025, which is N/A change from last year.
  • According to the latest figures from Q3 2025, AC Immune's Accumulated Expenses is $15.0 million, which was up 8.15% from $13.9 million recorded in Q2 2025.
  • In the past 5 years, AC Immune's Accumulated Expenses ranged from a high of $14.5 billion in Q3 2021 and a low of $13,810 during Q4 2024.
  • Moreover, its 3-year median value for Accumulated Expenses was $12.4 million (2025), whereas its average is $11.2 million.
  • Its Accumulated Expenses has fluctuated over the past 5 years, first soared by 121,233.71% in 2021, then tumbled by 99.92% in 2022.
  • AC Immune's Accumulated Expenses (Quarterly) stood at $18.2 million in 2021, then tumbled by 46.14% to $9.8 million in 2022, then grew by 27.87% to $12.5 million in 2023, then crashed by 99.89% to $13,810 in 2024, then rose by 0.70% to $15.0 million in 2025.
  • Its Accumulated Expenses stands at $15.0 million for Q3 2025, versus $13.9 million for Q2 2025 and $12.4 million for Q1 2025.